Inside Innovation

A report from Newmark announced that Cambridge, Massachusetts-headquartered pharmaceutical and biotech giant Moderna will support the Seattle’s market for office space by subleasing 54,350 square

Seattle-based biotech company Neoleukin Therapeutics announced that it will merge with Neurogene, a New York-based gene therapy organization. Finalization of the merger is expected to

A-Alpha Bio, a Seattle-based biotech company, raised $22.4 million to fund a machine learning project that will fuel its work to create therapeutic proteins. The

CBRE’s 2023 Scoring Tech Talent report declared Seattle as the second-best tech market in North America despite the industry’s ongoing layoffs. Seattle also ranked second

A 2023 report from the PeopleForBikes organization has ranked Seattle as the third most bikeable large U.S. city. Rankings were determined by accessibility to different

Seattle ranked second in a new Bankrate study discussing the best locations in America for starting a career. The city also came in first for

Seattle-based biologics company Just-Evotec has announced a new contract with the Department of Defense worth a potential $74 million. The collaboration aims to create monoclonal

Seattle biotech company MorphImmune is set to be acquired by Immunome, a biopharmaceutical firm based in Pennsylvania. As both organizations specialize in oncology, the move

Evergreen Bioscience Innovation chose a tentative location for its new headquarters in Spokane’s University District. The organization notes that this may change before plans are

Nonprofit organization Trust for Public Land ranked Seattle’s public park system as the eighth-best in the country. The study ranked the park systems of America’s

Washington’s life sciences continue to grow, with activity spurred by mergers and acquisitions. In fact, three of this year’s 10 largest biotech acquisitions nationwide have